Source disclosure: February 12, 2026
StemCell Institute [7096.T]
TOKYO, Feb 18 (Pulse News Wire) – Stemcell Institute (7096.T) reported consolidated results for Q3 FY2026 (ending March 2026). 14 billion.
03 billion with an equity ratio of 33.2%. For the next fiscal year, the company forecasts 00 billion.
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥2,144M | +218.0% |
| Operating profit | ¥228M | +146.0% |
| Net profit | n/a | n/a |
Next period forecast
Revenue
¥3,000M
+450.0%Op. profit
¥450M
+320.0%Source: TDNet filing · Figures in millions of yen
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.